MEDICAL SCIENCE MONITOR, cilt.11, sa.6, 2005 (SCI-Expanded)
Various biomarkers have prognostic value in non-small cell lung cancer (NSCLC). We aimed to identify the roles of P53, c-erb-B2 and p-glycoprotein (pgp) as prognostic factots, independently or in conjunction with each other, in operable NSCLC.